B. Braun Medical, a German infusion therapy company, has received the FDA’s approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida.
The facility, which is part of the company’s pledge to spend $1 billion on its U.S. manufacturing and supply chain to address shortages of IV fluids, will produce 0.9% sodium chloride for injection. The 1,000-milliliter and 500-milliliter bags won’t be made with PVC, DEHP or natural rubber latex, which can contain harmful chemicals to humans, the company said.
B. Braun expects to begin delivering products from the facility later this month.
